α-D2PV

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

Chemical compound



α-D2PV (α-diphenyl-2-pyrrolidinylvalerophenone) is a synthetic stimulant of the cathinone class. It is structurally related to α-PVP and is known for its psychoactive effects. This compound has been used in scientific research to study its pharmacological properties and potential effects on the central nervous system.

Chemical structure and properties[edit | edit source]

Chemical structure of α-D2PV

α-D2PV is a derivative of the cathinone class, characterized by the presence of a pyrrolidine ring attached to the α-carbon of the ketone moiety. The chemical structure of α-D2PV includes a diphenyl group, which is responsible for its name. The presence of the pyrrolidine ring is a common feature in many synthetic stimulants, contributing to their psychoactive properties.

The molecular formula of α-D2PV is C21H25NO, and it has a molar mass of 307.43 g/mol. The compound is typically synthesized in a laboratory setting and is not found naturally.

Pharmacology[edit | edit source]

α-D2PV acts as a central nervous system stimulant. It is believed to exert its effects by inhibiting the reuptake of neurotransmitters such as dopamine and norepinephrine, leading to increased concentrations of these chemicals in the synaptic cleft. This mechanism of action is similar to that of other stimulants in the cathinone class.

The psychoactive effects of α-D2PV can include increased alertness, euphoria, and enhanced cognitive function. However, the use of α-D2PV can also lead to adverse effects such as anxiety, paranoia, and cardiovascular issues.

Legal status[edit | edit source]

The legal status of α-D2PV varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. In others, it may be unregulated, although this is subject to change as new legislation is enacted.

Research and applications[edit | edit source]

Research on α-D2PV is limited, but it is of interest in the field of neuropharmacology for its potential to provide insights into the functioning of the central nervous system. Studies may focus on its effects on neurotransmitter systems, its potential therapeutic applications, and its safety profile.

Safety and toxicity[edit | edit source]

The safety and toxicity of α-D2PV have not been extensively studied. As with many synthetic stimulants, there is a risk of overdose and adverse effects, particularly with high doses or prolonged use. Users may experience symptoms such as increased heart rate, hypertension, and psychological disturbances.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD